The pediatric cancer segment is holds the largest share of 24.8% of the particle therapy market in 2021 with CAGR of 10.4% during the forecast period.
Particle therapy is a type of radiation therapy used to treat cancer. It is a form of external beam radiation therapy that uses beams of high energy particles to target and destroy cancer cells. Particle therapy has been shown to be more effective than traditional radiation therapy in some cases, as the particles are able to more precisely target the cancer cells while minimizing damage to the surrounding healthy tissue.
The global particle therapy market is expected to reach $2.6 billion by 2027, growing at a compound annual growth rate (CAGR) of 11.8% from 2020 to 2027. Key factors driving the growth of the market include the increasing prevalence of cancer, technological advancements in particle therapy, and increasing investments in healthcare.
ππ‘ππ’π¬ πππ° ππ¨π« ππππ?
· Detailed industry forecast
· Additional information on organization participation
· On-demand custom reports and expert assistance
· Recent market trends and future growth prospects
· Requested specific regional/country reports
Request for sample Report @ https://www.prnewswire.com/news-releases/particle-therapy-market-worth-1-004-million-by-2027--exclusive-report-by-marketsandmarkets-301557214.html
The particle therapy market is segmented based on type, products, services, system, cancer type, application, and geography. On the basis of type, the market is divided into proton therapy and heavy ion therapy. Proton therapy is expected to dominate the market due to its ability to deliver high precision radiation to target tumors while sparing nearby healthy tissue.
Based on product, the particle therapy market is segmented into cyclotron, synchrotron, and synchrocyclotron. The cyclotron market is expected to account for the largest market share due to its ability to generate higher energy beams compared to the others.
By services, the particle therapy market is divided into installation, training, and maintenance. The maintenance segment is expected to account for the largest share of the market due to the need for regular maintenance and repairs of particle therapy systems.
By system, the market is divided into single-room and multi-room. The single-room system is expected to account for the largest share of the market due to its cost effectiveness and easy installation.
By cancer type, the market is divided into pediatric and prostate cancer. The pediatric cancer segment is expected to account for the largest share of the market due to the increasing prevalence of pediatric cancer in developed countries.
By application, the particle therapy market is divided into treatment and research. The treatment segment is expected to account for the largest share of the market due to the increasing demand for particle therapy to treat various forms of cancer.
Geographically, the particle therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is expected to account for the largest share of the market due to the increasing prevalence of cancer, technological advancements, and increasing investments in healthcare.
For More Information or Query or Customization Before Buying, Visit @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=12809137
Key Market Players
The major players in the particle therapy market include The RaySearch Laboratories AB, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, IBA, ProTom International Corporation, Particle Therapy Co-Operative Group, Hitachi Ltd., Optivus Proton Therapy, Inc., and ProNova Solutions, LLC.
πππ©π¨π«π πππ¨π©π
· The objective of this report is to deliver a detailed overview of the worldwide Particle Therapy market, incorporating both quantitative and qualitative analysis. Its purpose is to aid readers in formulating business and growth strategies, evaluating the competitive landscape, examining their current market position, and making informed decisions related to Particle Therapy.
· This report presents estimates and projections of the sales volume and revenue of the Particle Therapy market, with 2030 as the baseline year and historical and forecast data spanning from 2023 to 2030. The Particle Therapy market is segmented in a comprehensive manner, with regional market sizes provided for different product types, applications, and players.
· To enhance comprehension of the market, this report offers profiles of the competitive landscape, key competitors, and their market rankings. Additionally, it examines technological trends and recent product advancements.
· This report provides Particle Therapy manufacturers, new market entrants, and industry chain-related companies with valuable insights into the revenues, sales volume, and average prices of the overall market and its sub-segments, categorized by company, product type, application and region.
Key Questions Answered In The Report:
1. Which regional market will experience the greatest and most rapid growth?
2. Who are the top five Particle Therapy Market players?
3. How will the Particle Therapy Market evolve over the next six years?
4. What application and product will dominate the Particle Therapy Market?
5. What are the market drivers and constraints for Particle Therapy Market?
6. What will be the Particle Therapy Market’s CAGR and size during the forecast period?
Make an Enquire to by this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=12809137
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com